無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の体外診断 (IVD) 市場

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2018-2022

発行 Koncept Analytics 商品コード 223486
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.89円で換算しております。
Back to Top
世界の体外診断 (IVD) 市場 Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2018-2022
出版日: 2018年09月24日 ページ情報: 英文 82 Pages
概要

当レポートでは、世界における体外診断 (IVD) 市場の発展動向を分析しており、市場の成長促進要因と課題、地域別市場の主な動向、主要企業の市場シェア/プロファイルなどを提供しています。

第1章 概要

  • IVD製品の種類
  • IVD検査
  • 技術別のIVD市場
  • IVDの利用
  • IVDのバリューチェーン分析

第2章 世界のIVD市場

  • 収益
  • 収益予測
  • 地域別市場
  • 製品タイプ別市場
  • 検査ロケーション別市場
  • 技術別市場

第3章 世界のIVD市場:技術別

  • 血糖自己測定 (SMBG) 市場の収益予測
  • 臨床化学市場の収益予測
  • 免疫化学市場
  • 分子診断市場
  • ポイントオブケア (POC) 市場の収益予測
  • 微生物学市場の収益予測
  • 血液学市場の収益予測

第4章 IVDの地域別市場

  • 北米
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • ラテンアメリカ

第5章 市場力学

  • 成長促進要因
  • 主要動向
  • 課題

第6章 競合情勢

  • IVD市場におけるシェア
  • 免疫化学市場におけるシェア
  • 分子診断市場におけるシェア
  • POCT市場におけるシェア
  • 臨床化学市場におけるシェア

第7章 企業プロファイル

目次

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient's body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases.

The global IVD market is experiencing a lucrative growth due to rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine. Also, there are various companies developing syndromic testing panels and using human microbiomes in the IVD.

On the basis of technology, the global IVD market remained dominated by immunodiagnostics and blood glucose self-monitoring segments owing to the strong base of older population and diabetic population. On product basis, the reagents acquired a major share in the global IVD market, followed by instruments. Instruments segment would hold a higher share in the coming years due to increasing demand of personalized medicines among patients.

Regionally, North America contributed a major chunk to the global IVD market primarily due to recent introduction of new novel reagents and wide availability of effective and cost-efficient reagents. However, Asia-Pacific region is holding the highest growth rate due to swiftly growing economies of India and China, increase in gross domestic product, and the rising disposable income.

The competitive landscape of global IVD market is quite consolidated with four key players including Siemens AG, Danaher Corporation, Roche Holding, and Abbott Laboratories. Due to the strong presence of these companies in the market, new entrants might find it difficult to penetrate the market with their products.

1. Overview

  • 1.1 In-Vitro Diagnostics (IVD)
  • 1.2 IVD Product by Types
  • 1.3 IVD Tests
  • 1.4 IVD Market by Technology
  • 1.5 IVD Uses
  • 1.6 IVD Value Chain Analysis

2. Global IVD Market

  • 2.1 Global IVD Market Forecast by Value
  • 2.2 Global IVD Market by Region
  • 2.3 Global IVD Market by End Users
  • 2.4 Global IVD Market by Product
    • 2.4.1 Global IVD Reagents Market Forecast by Value
    • 2.4.2 Global IVD Instrument Market Forecast by Value
  • 2.5 Global IVD Market by Technology
    • 2.5.1 Global Immunodiagnostics Market Forecast by Value
    • 2.5.2 Global Immunodiagnostics Market by Indications
    • 2.5.3 Global Molecular Diagnostics Market Forecast by Value
    • 2.5.4 Global Molecular Diagnostics Market by Indications
    • 2.5.5 Global Hematology Market Forecast by Value
    • 2.5.6 Global Point Of Care (POC) Market Forecast by Value
    • 2.5.7 Global Point Of Care (POC) Market by Type
    • 2.5.8 Global Clinical Chemistry Market Forecast by Value
    • 2.5.9 Global Microbiology Market Forecast by Value
    • 2.5.10 Global SMBG Market Forecast by Value

3. Regional IVD Market

  • 3.1 North America
    • 3.1.1 North America IVD Market Forecast by Value
    • 3.1.2 The US IVD Market Forecast by Value
  • 3.2 EMEA
    • 3.2.1 EMEA IVD Market Forecast by Value
  • 3.3 Asia-Pacific
    • 3.3.1 Asia-Pacific IVD Market Forecast by Value
    • 3.3.2 China IVD Market Forecast by Value
    • 3.3.3 Japan IVD Market Forecast by Value
    • 3.3.4 Australia IVD Market Forecast by Value
    • 3.3.5 India IVD Market Forecast by Value
  • 3.4 Latin America
    • 3.4.1 Latin America IVD Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Increasing Diabetic Patient Base
    • 4.1.2 Surge in Incidences of Chronic Ailments
    • 4.1.3 Increasing Global Healthcare Expenditure
    • 4.1.4 Increasing Disposable Income
    • 4.1.5 Growing Geriatric Population
  • 4.2 Key Trends & Developments
    • 4.2.1 Development of Syndromic Panel
    • 4.2.2 Liquid Biopsy for Cancer Testing
    • 4.2.3 Applications of Human Microbiome in IVD
  • 4.3 Challenges
    • 4.3.1 Government Regulation for IVD Tests

5. Competitive Landscape

  • 5.1 Global IVD Market
    • 5.1.1 Revenue and Market Cap. Comparison
    • 5.1.2 Global IVD Market Share by Company
    • 5.1.3 Global Molecular Diagnostics Market Share by Company
    • 5.1.4 Global Immunodiagnostics Market Share by Company
    • 5.1.5 Global POCT Market Share by Company

6. Company Profiles

  • 6.1 Siemens AG
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Roche Holding AG
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Abbott Laboratories
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Danaher Corporation
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Types of Diagnostics
  • Types of IVD Products
  • Types of IVD Tests
  • IVD Market by Technology
  • IVD Value Chain Analysis
  • Global IVD Market Forecast by Value (2017-2022)
  • Global IVD Market by Region (2017)
  • Global IVD Market by End Users (2017)
  • Global IVD Market by Product (2017)
  • Global IVD Reagents Market Forecast by Value (2017-2022)
  • Global IVD Instrument Market Forecast by Value (2017-2022)
  • Global IVD Market by Technology (2017)
  • Global Immunodiagnostics Market Forecast by Value (2017-2022)
  • Global Immunodiagnostics Market by Indications (2017)
  • Global Molecular Diagnostics Market Forecast by Value (2017-2022)
  • Global Molecular Diagnostics Market by Indications (2017)
  • Global Hematology Market Forecast by Value (2017-2022)
  • Global Point Of Care (POC) Market Forecast by Value (2017-2022)
  • Global Point Of Care (POC) Market by Type (2017)
  • Global Clinical Chemistry Market Forecast by Value (2017-2022)
  • Global Microbiology Market Forecast by Value (2017-2022)
  • Global SMBG Market Forecast by Value (2017-2022)
  • North America IVD Market Forecast by Value (2017-2022)
  • The US IVD Market Forecast by Value (2017-2022)
  • EMEA IVD Market Forecast by Value (2017-2022)
  • Asia-Pacific IVD Market Forecast by Value (2017-2022)
  • China IVD Market Forecast by Value (2017-2022)
  • Japan IVD Market Forecast by Value (2017-2022)
  • Australia IVD Market Forecast by Value (2017-2022)
  • India IVD Market Forecast by Value (2017-2022)
  • Latin America IVD Market Forecast by Value (2017-2022)
  • Global Diabetes Patient Volume Forecast (2014/2035)
  • Global New Cancer Patients Volume (2013-2017)
  • Global Healthcare Expenditure Per Capita (2013-2017)
  • Global GNI per Capita (2013-2017)
  • Global Population above 64 Years (2013-2017)
  • Global IVD Market Share by Company (2017)
  • Global Molecular Diagnostics Market Share by Company (2017)
  • Global Immunodiagnostics Market Share by Company (2017)
  • Global POCT Market Share by Company (2017)
  • Siemens AG Revenue by Segment (2017)
  • Siemens AG Revenue and Net Income (2013-2017)
  • Siemens R&D Expenditure (2015-2017)
  • Roche Sales by Segments (2017)
  • Roche Sales and Net Income (2013-2017)
  • Abbott Laboratories Sales by Segment (2017)
  • Abbott Laboratories Net Sales and Net Earnings (2013-2017)
  • Abbott Laboratories R&D Expenditure (2015-2017)
  • Danaher Corp. Revenue by Segments (2017)
  • Danaher Corp. Revenue and Net Earnings (2013-2017)
  • Danaher Corp. R&D Expenditure (2014-2016)

List of Tables

  • Revenue and Market Cap. Comparison by Company (2017)
  • Roche Agreements (2017/2018)
  • Roche Product Approvals (2018)
Back to Top